Zdrowie i gospodarka · 20/05/2021

FDA Clears AVACLYR (Acyclovir Ophthalmic Ointment) for Approval, Citing Lack of Safety or Effectiveness Concerns

The FDA has determined that AVACLYR, a 3% acyclovir ointment, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications